Literature DB >> 4808472

Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines.

H J Schaeffer, C F Schwender.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4808472     DOI： 10.1021/jm00247a002

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  42 in total

1.  Isolation and characterization of purine-nucleoside phosphorylase-deficient T-lymphoma cells and secondary mutants with altered ribonucleotide reductase: genetic model for immunodeficiency disease.

Authors:  B Ullman; L J Gudas; S M Clift; D W Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

Review 2.  Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.

Authors:  Thérèse Keravis; Claire Lugnier
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.

Authors:  D R Averett; G W Koszalka; J A Fyfe; G B Roberts; D J Purifoy; T A Krenitsky
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

4.  cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes.

Authors:  M Rivet-Bastide; G Vandecasteele; S Hatem; I Verde; A Bénardeau; J J Mercadier; R Fischmeister
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

Review 5.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

6.  Inhibition of lymphocyte-mediated cytolysis by 3-deazaadenosine: evidence for a methylation reaction essential to cytolysis.

Authors:  T P Zimmerman; G Wolberg; G S Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

7.  Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.

Authors:  T W North; S S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

8.  Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virus.

Authors:  P de Miranda; T C Burnette; K K Biron; R L Miller; D R Averett; T A Krenitsky
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

9.  erythro-9-[3-(2-Hydroxynonyl)]adenine is an effective inhibitor of cell motility and actin assembly.

Authors:  M Schliwa; R M Ezzell; U Euteneuer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

10.  Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.

Authors:  W M Shannon; G Arnett; F M Schabel; T W North; S S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.